Other: human milk derived fortifier (DrugBank: Milk)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 210 | 単心室症 | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02860702 (ClinicalTrials.gov) | July 2016 | 28/7/2016 | Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology | A Randomized Controlled Trial to Evaluate Growth Velocity and Clinical Outcomes of Infants With Single Ventricle Physiology Fed an Exclusive Human Milk Diet With Early Nutritional Fortification Following Surgical Repair | Congenital Heart Defect | Other: Human Milk Derived Fortifier;Other: Human/Bovine Milk | The University of Texas Health Science Center at San Antonio | Prolacta Bioscience;Baylor College of Medicine;Children's Hospital Medical Center, Cincinnati;Columbia University;University of Oklahoma;Ann & Robert H Lurie Children's Hospital of Chicago;Cook Children's Medical Center;Children's Hospital of Orange County;University of Texas;University of Florida | Recruiting | N/A | 7 Days | All | 100 | N/A | United States |